Mar 14, 2018, 08:20 AM by Michael Croft

Mar 14, 2018, 07:59 AM by Michael Croft

KAYSERSBERG, FRANCE - Mar 14, 2018 - Recipharm, the contract development and manufacturing organisation (CDMO), announces its new blow-fill-seal machinery is now operational following a substantial investment last year at its facility in Kaysersberg, France

Mar 14, 2018, 07:57 AM by Michael Croft

CRAMLINGTON, UK - Mar 14, 2018 - Nanologica AB (publ) has entered into a service agreement with global contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions for the large-scale production of silica particles

Mar 13, 2018, 10:13 AM by Michael Croft

PRINCETON, NJ - Mar 13, 2018 - Certara®, the global leader in model-informed drug development and regulatory science, today announced the launch of its Quantitative Systems Pharmacology (QSP) Immuno-oncology Simulator Consortium

Mar 13, 2018, 10:00 AM by Michael Croft

STOCKHOLM, SWEDEN - Mar 13, 2018 - Recipharm has announced that its 2017 International Environmental Award will be presented to Karen Kidd, Professor in Biology, and Geography & Earth Sciences at McMaster University in Hamilton, Ontario and Jarislowsky Chair in Environment and Health

Mar 13, 2018, 08:50 AM by Michael Croft

STAT | Backed by a growing body of evidence, software is itself becoming a prescription for diseases ranging from depression to heart disease, and drug companies are starting to take notice.

Mar 12, 2018, 17:00 PM by Michael Croft

Bio-IT World News Brief | WuXi NextCODE has named a new CEO: Rob Brainin, Executive Vice President and Chief Operating Officer, has been appointed as the company’s new Chief Executive Officer effective today. Brainin succeeds Hannes Smárason, who will work as a senior advisor for the company as he pursues other entrepreneurial activities, according to the company.

Mar 12, 2018, 08:26 AM by Michael Croft

PRINCETON, NJ - Mar 12, 2018 - Mar. 12, 2018 – Certara®, the global leader in model-informed drug development and regulatory science, today announced that it is partnering with faculty at the UNC Eshelman School of Pharmacy to launch the Model-informed Drug Development (MIDD) Gran Prix at the 2018 American Society for Clinical Pharmacology & Therapeutics (ASCPT) Annual Meeting

Mar 12, 2018, 05:48 AM by Michael Croft

CAMBRIDGE, UK - Mar 12, 2018 - Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe

Mar 9, 2018, 12:36 PM by Michael Croft

WIRED | Machine learning systems, like those used in self-driving cars, can be tricked into seeing objects that don't exist. Defenses proposed by Google, Amazon, and others are vulnerable too.

Mar 9, 2018, 11:35 AM by Michael Croft

PRINCETON, NJ, US - Mar 7, 2018 - Bioclinica®, the world-leading provider of scientific- and technology-enabled solutions for clinical research, is pleased to announce its cloud-based research image management technology, 'SMART Submit,' was recognized with a Clinical Informatics News Best Practices Award

Mar 8, 2018, 11:48 AM by Michael Croft

LONDON, UNITED KINGDOM - Mar 8, 2018 - Clinithink has helped to achieve a GUINNESS WORLD RECORDS title for the Fastest genetic diagnosis

Mar 7, 2018, 12:00 PM by Michael Croft

Bio-IT World  | WuXi NextCODE today announced a partnership with Google Cloud. WuXi NextCODE’s core suite of capabilities—including GORdb, WuXi NextCODE secondary analysis, the Sequence Miner case-control research application, and the Clinical Sequence Analyzer clinical interpretation system—will be hosted on Google Cloud and available on the Google Cloud Launcher marketplace.

Mar 7, 2018, 11:22 AM by Michael Croft

NEWTON, MA, UNITED STATES - Mar 7, 2018 - HIMSS 2018 - LAS VEGAS - March 7, 2018 - 2bPrecise®, LLC, and The Innovation Institute announced today that they have entered into an agreement that lays the foundation for 2bPrecise to deliver a pharmacogenomics knowledge base to the point of care for The Innovation Institute's network of member providers, as well as others beyond the network

Mar 7, 2018, 05:30 AM by Michael Croft

COVENTRY, UK - Mar 7, 2018 - Medherant Ltd, a leader in next-generation transdermal drug delivery, is pleased to announce the appointment of a new senior executive, David Davies, as Head of Development

Mar 7, 2018, 03:27 AM by Michael Croft

BOSTON, MA - Mar 7, 2018 - BC Platforms, a pioneer in genomic data management and analytics, today announces it has launched GeneVision, a new end-to-end Solution for Precision Medicine, that uses the Microsoft Genomics service which runs on Microsoft Azure

Mar 6, 2018, 12:50 PM by Michael Croft

Bio-IT World News Brief | FDA today authorized a direct-to-consumer genetic test for cancer risk. The authorization allows 23andMe to provide customers, without a prescription, information on three genetic variants found on the BRCA1 and BRCA2 genes known to be associated with higher risk for breast, ovarian, and prostate cancer.

Mar 6, 2018, 09:37 AM by Michael Croft

MELBOURNE, AUSTRALIA - Mar 6, 2018 - Shivom, the blockchain-powered global ‘Unique ID’ genomic database platform, has today announced a major partnership with leading molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) that is expected to accelerate the prediction of cancer for millions of individuals worldwide

Mar 6, 2018, 05:43 AM by Michael Croft

BOSTON, MA - Mar 6, 2018 - BC Platforms, a world leader in genomic data management and analytics, announces that it has been selected by Gene By Gene, the industry leader in offering integrated multi-disciplinary genetic testing services, to scale up its genomic data processing and storage capabilities

Mar 5, 2018, 13:50 PM by Michael Croft

Bio-IT World Bioinformatics.org has announced five finalists for the 2018 Benjamin Franklin Award for Open Access in the Life Sciences, including the first finalist team. Voting will be open until Monday, March 12. Finalists are Christine Durinx, SIB Swiss Institute of Bioinformatics & Johanna McEntyre, EMBL-EBI; Melissa Haendel, Oregon Health and Science University; Desmond Higgins, University College Dublin (UCD) Conway Institute; B.F. Francis Ouellette, Ontario Institute of Cancer Research; and Frank W. Rockhold, Duke University Medical Center.